Saturday, February 11, 2006


HCV - Hepatitis C - Page 1


Hepatitis C - Page 1
... and the development of antibody screening tests, the number of newly acquired acute hepatitis C infection has decreased ...

Hepatitis C
... 2.7 million peopleor about 1.5% of the US populationhave chronic hepatitis C infection.3 ... Although any patient with hepatitis C infection can be considered for therapy ...

Management of Hepatitis C (CBM 97-1)
... of serum RNA associated with hepatitis C infection suggesting heterogeneity of the agent ... associated with acute and chronic hepatitis C infection generated from patients serum ...

Hepatitis C
... will obtain long-term control or cure their hepatitis C infection. Certain factors, such as obesity (BMI of 30 ...

Hepatitis C - New Treatment Helps Some, But Cure Remains Elusive - StopGettingSick News
... is no vaccine or other means of preventing hepatitis C infection. HCV exists in many different forms, called genotypes ...

HCV - AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus ...


AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus ...
PharmaLive.com (press release), PA - Jan 13, 2006... this approach can be, but it is also encouraging for our work in treating additional viral diseases, such as chronic hepatitis C infection, which currently ...

Schering-Plough drug gets fast track
BusinessWeek - Jan 30, 2006... The drug, known as SCH 503034, is an oral therapy in mid-stage human studies testing it as a treatment for chronic hepatitis C infection. ...

BioCryst Reports Fourth Quarter and Year-End 2005 Financial ...
International News Service, Australia - Feb 8, 2006... Early in 2005 we isolated a lead compound in our polymerase inhibitor program, BCX-4678 for the treatment of patients with hepatitis C infection. ...

Peregrine accelerates Tarvacin development
Pharmaceutical Business Review - Jan 19, 2006... Peregrine. In the phase I trial, a single dose of Tarvacin is being tested in patients with chronic hepatitis C infection. Data ...

Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PR Newswire (press release), NY - Feb 9, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...

Friday, February 10, 2006


HCV - WHO | Hepatitis C


WHO | Hepatitis C
This site only. Media centre. Fact sheet N 164. Revised October 2000. Hepatitis C ... Hepatitis C. Hepatitis C is a viral infection of the liver which had been referred to as parenterally1 ... discovery and characterization of the hepatitis C virus (HCV) led to the ...

Hepatitis A, B, and C: Learn the Differences
P4075 This chart teaches the differences between hepatitis A, B, and C. ... Hepatitis A. Hepatitis B. Hepatitis C ...

Hepatitis C and Chimpanzees
Americans For Medical Advancement. Europeans For Medical Advancement. Japanese For Medical Advancement. Hepatitis C and Chimpanzees. Are chimpanzees useful in HCV research? ... Hepatitis C. Hepatitis C infection is estimated to have infected 3% of the population of the planet or 170-200 ...

Hepatitis C
Hepatitis C. By Howard J. Worman, M. D. The Hepatitis C Virus (HCV) HCV was discovered in 1989 by investigators at Chiron, Inc. ... A, non-B hepatitis. They called the new virus hepatitis C virus (HCV). Subsequently, the complete genomes of various HCV ...

Hepatitis C
Hepatitis C - origins, spread and treatment. ... The origins and epidemiology of hepatitis C. Estimates of the number of people exposed to the hepatitis C virus, (HCV), world-wide vary ...

Hepatitis Innovations
Schering Corporation offers information about the disease, treatment, products, and more.

Thursday, February 09, 2006


HCV - Weight-based Treatment of HCV


Weight-based Treatment of HCV
Weight-based dosing has always made sense to us. We don't really understand why Roche has not changed their dosing to weight-based. Although the difference is subtle, it is certainly significant according to this study. You must also note, though, that...

Doctor: Checklist to Take To Your Doctor's Appointment
Title: Doctor: Checklist to Take To Your Doctor's AppointmentCategory: Health FactsCreated: 7/13/2005Last Editorial Review: 7/14/2005

MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

HCV - Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...


Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...
PR Newswire (press release), NY - Jan 18, 2006... and Dosing in Initial Phase I Trial Now Scheduled for Completion in February - - Preliminary Phase I Safety Data to Be Presented at 'Viral Hepatitis in Drug ...

Viral Hepatitis and HIV Coinfection
Medscape (subscription) - Feb 3, 2006... Although this unfortunate 3-month delay reduced the attraction of the conference, presentations regarding HIV and viral hepatitis coinfection were among the ...

Hepatitis C screening urged
Hindu, India - Feb 3, 2006... The survey was conducted by the University's Institute of Basic Medical Sciences which was a national referral centre for viral hepatitis. ...

Health announcements
Annapolis Capital, MD - Jan 29, 2006... Information will be provided regarding viral hepatitis and liver disease, current treatments and answers to any liver-related questions. ...

Wednesday, February 08, 2006


HCV - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Tuesday, February 07, 2006


HCV - SCH 503034 Jumps on the Fast Track


SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Healthy Habits: What Your Doctor Wants You To Know
Title: Healthy Habits: What Your Doctor Wants You To KnowCategory: Doctor's ViewsCreated: 12/9/2005Last Editorial Review: 12/22/2005

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

Monday, February 06, 2006


HCV - Highlights of rising and falling U.S. stocks


Highlights of rising and falling U.S. stocks
Investors Business Daily - Alliant Techsystems Inc. ( ATK ) said third-quarter net income slipped to $47 million from $47.9 million a year ago. Earnings edged higher to $1.26 a share from $1.25 a share. Sales rose 15% to $2.3 billion on a strong performance from its ammunition

Viral Hepatitis and HIV Coinfection
Medscape News - In Western countries, chronic HBV infection affects 5% to 10% of HIV-positive individuals. However, a larger proportion of the HIV-infected population has been exposed to HBV in the past. Isolated hepatitis B core antibody (anti-HBc) is more common

Killer told dozen-plus renditions of shooting
Fort Wayne Journal Gazette - AUBURN In a two-hour rambling statement to police, accused murderer David Barany changed his story multiple times about the fatal shooting of a friend. Jurors watched video of Barany s statement during the fourth day of his murder trial

Son helps save dad
Pittsburgh Tribune-Review - Diagnosed with liver cancer and given six months to live, William Higginbotham Sr. needed a miracle. He got one from his son, William Jr. Nicknamed "Little Will" by his family, William Higginbotham Jr. volunteered to donate a portion of his liver to

HCV - Hepatitis C Patients Taxing Medical System


Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Pill Form of Therapy for HCV Coming Closer
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases). Three separate approaches are covered. Yes, progress is being made....

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

HCV Vaccine Progress
The development of a HCV vaccine is very exciting, even to patients already infected. Although the vaccine will not help them direcly, it shows definite progress in understanding and outsmarting this virus that is known to be difficult to combat...

Sunday, February 05, 2006


HCV - Hepatitis C Virus Lives In Your Liver(NC)-Your liver

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>



HCV - Viral Hepatitis and HIV Coinfection


Viral Hepatitis and HIV Coinfection
Medscape News - In Western countries, chronic HBV infection affects 5% to 10% of HIV-positive individuals. However, a larger proportion of the HIV-infected population has been exposed to HBV in the past. Isolated hepatitis B core antibody (anti-HBc) is more common

Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership
Genetic Engineering News - Inovio Biomedical Corporation (AMEX:INO), a late stage developer of cancer and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has signed an agreement with Swedish-based Tripep AB (The Stockholm

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in Acceleration
RxPG - "The initial success of our efforts to accelerate the HCV clinical trial program for Tarvacin Anti-Viral is gratifying in view of Tarvacin's promise as an important new treatment option for a number of viral infections, including chronic hepatitis C

Schering-Plough Drug Gets Fast Track
MSN MoneyCentral - KENILWORTH, N.J. (AP) - Drug maker Schering-Plough Corp. said Monday that regulators granted "fast track" status to its experimental hepatitis C treatment. The Food and Drug Administration gives the fast track label -- which sometimes helps speed the

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor SCH
Medical News Today - Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment